Cargando…
Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is one of the fatal tumors and is associated with a poor prognosis. Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was used to quantify the proportions of 22 types of immune cells. Weighted gene co-expression network analysis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806742/ https://www.ncbi.nlm.nih.gov/pubmed/34369264 http://dx.doi.org/10.1080/21655979.2021.1960764 |
_version_ | 1784643526295814144 |
---|---|
author | Chen, Binglin Xie, Xiaowei Lan, Feifeng Liu, Wenqi |
author_facet | Chen, Binglin Xie, Xiaowei Lan, Feifeng Liu, Wenqi |
author_sort | Chen, Binglin |
collection | PubMed |
description | Non-small cell lung cancer (NSCLC) is one of the fatal tumors and is associated with a poor prognosis. Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was used to quantify the proportions of 22 types of immune cells. Weighted gene co-expression network analysis (WGCNA) was established from the GSE37745 data, and key modules correlating most with CD8(+) T cell infiltration were determined. Genes that manifested a high module connectivity in the key module were identified as hub genes. Three bioinformatics online databases were used to evaluate hub gene expression levels in tumor and normal tissues. Finally, survival analysis was conducted for these hub genes. In this study, we chose four hub genes (AURKB, CDC20, TPX2 and KIF2C) based on the comprehensive bioinformatics analyses. All hub genes were overexpressed in tumor tissue, and high expression of AURKB, CDC20, TPX2, and KIF2C correlated with the poor prognosis of these patients. In vitro experiments confirmed that CDC20 knockdown inhibited cell proliferation and growth. The above results indicated that AURKB, CDC20, TPX2, and KIF2C are potential CD8(+) T cell infiltration-related biomarkers and therapeutic targets. |
format | Online Article Text |
id | pubmed-8806742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88067422022-02-02 Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer Chen, Binglin Xie, Xiaowei Lan, Feifeng Liu, Wenqi Bioengineered Research Paper Non-small cell lung cancer (NSCLC) is one of the fatal tumors and is associated with a poor prognosis. Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was used to quantify the proportions of 22 types of immune cells. Weighted gene co-expression network analysis (WGCNA) was established from the GSE37745 data, and key modules correlating most with CD8(+) T cell infiltration were determined. Genes that manifested a high module connectivity in the key module were identified as hub genes. Three bioinformatics online databases were used to evaluate hub gene expression levels in tumor and normal tissues. Finally, survival analysis was conducted for these hub genes. In this study, we chose four hub genes (AURKB, CDC20, TPX2 and KIF2C) based on the comprehensive bioinformatics analyses. All hub genes were overexpressed in tumor tissue, and high expression of AURKB, CDC20, TPX2, and KIF2C correlated with the poor prognosis of these patients. In vitro experiments confirmed that CDC20 knockdown inhibited cell proliferation and growth. The above results indicated that AURKB, CDC20, TPX2, and KIF2C are potential CD8(+) T cell infiltration-related biomarkers and therapeutic targets. Taylor & Francis 2021-08-08 /pmc/articles/PMC8806742/ /pubmed/34369264 http://dx.doi.org/10.1080/21655979.2021.1960764 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Chen, Binglin Xie, Xiaowei Lan, Feifeng Liu, Wenqi Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
title | Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
title_full | Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
title_fullStr | Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
title_full_unstemmed | Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
title_short | Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
title_sort | identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806742/ https://www.ncbi.nlm.nih.gov/pubmed/34369264 http://dx.doi.org/10.1080/21655979.2021.1960764 |
work_keys_str_mv | AT chenbinglin identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer AT xiexiaowei identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer AT lanfeifeng identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer AT liuwenqi identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer |